Of note, in a mouse model of lung and colon carcinomas immunotherapy has failed to induce EZH2 expression, suggesting a melanoma-specific role of PRC2 in controlling immune evasion (Zingg et al., 2017). This evidence concerns the gene EZH2 and melanoma.